The business leaders at the JPM meeting saw a weird looking guy with funny accent who tried to convince them that 1 study is enough (whereas 2 pivotal studies are the standard), that the frequent occurrence of dizziness is not really an adverse event but something 'naturally of the brain' (was he joking?). Furthermore, that long term OL effects are even better (but nobody understands the slide and wonders how a one arm extension study can be blinded) and that the woke company aims for community engagement with core principles of co-equal, co-created, and is culturally centered and equitably financed (slide 29, whatever it means). After that the share price dropped 20% and the market capital is still below 1B despite promising data. Yeah, it’s all because of big pharma conspiracies and fudsters.
Market Data 
Markets 
AI
